Atlas Trials

Evaluation of Proteasome as a Marker of Hepatocellular Carcinoma in Cirrhotic Patients Following Curative Treatment

Clinical trial NCT01492127 · UNKNOWN

Trial details

NCT number
NCT01492127
Sponsor
University Hospital, Montpellier
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
Hepatocellular CarcinomaCirrhosis
Start date
2011-12-01
Primary completion
2014-03-01
Enrollment
64

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.